Preferential role of intracellular Ca2+ stores in regulation of isometric force in NIH 3T3 fibroblast fibres

J Physiol. 2000 Dec 15;529 Pt 3(Pt 3):669-79. doi: 10.1111/j.1469-7793.2000.00669.x.

Abstract

Fibroblast contraction plays a major role in wound repair, but the regulatory mechanisms are not well known. We investigated the relations between isometric force and intracellular calcium concentration ([Ca2+]i) in fibroblast fibres. These fibres were made with mouse NIH 3T3 fibroblasts cultured with native collagen in a three-dimensional matrix. Calf serum (CS; 30%) elicited a monotonic increase in force that attained a maximum within 15 min and could be sustained indefinitely. In contrast, [Ca2+]i increased to a peak at 3 min after CS stimulation, then returned to baseline levels by 10 min. Pretreatment with Ca2+-free medium or the Ca2+-channel antagonist nicardipine (10 microM) blocked the CS-induced [Ca2+]i increase, but force was not affected. KCl (50 mM) stimulation on the other hand, elicited a prolonged increase in [Ca2+]i but did not increase force. Inhibition of the endoplasmic reticulum Ca2+ release with Ca2+-ATPase inhibitors cyclopiazonic acid (5 microM) or thapsigargin (5 microM) nearly abolished (<20% control) the increase in [Ca2+]i and force response to CS. Treatment with ryanodine (10 microM) and caffeine (20 mM) had a similar effect. The phospholipase C inhibitor U73122 (3 microM) reduced the CS-induced increases in [Ca2+]i and force by 70 and 40%, respectively. We conclude that fibroblast isometric force is not coupled to Ca2+ arising from transmembrane influx but is correlated with the transient [Ca2+]i increase due to release from intracellular stores. Store-released Ca2+ may initiate activation pathways for fibroblast force development, but is not required for force maintenance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells
  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism
  • Calcium-Transporting ATPases / antagonists & inhibitors
  • Cattle / blood
  • Drug Synergism
  • Endoplasmic Reticulum / metabolism
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / physiology*
  • Indoles / pharmacology
  • Intracellular Membranes / metabolism
  • Mice
  • Nicardipine / pharmacology
  • Potassium Chloride / pharmacology
  • Pyrrolidinones / pharmacology
  • Ryanodine / pharmacology
  • Thapsigargin / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Inhibitors
  • Estrenes
  • Indoles
  • Pyrrolidinones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Ryanodine
  • Caffeine
  • Potassium Chloride
  • Thapsigargin
  • Nicardipine
  • Type C Phospholipases
  • Calcium-Transporting ATPases
  • Calcium
  • cyclopiazonic acid